| Dr Fayak S Kamili, MD | |
|
3006 Webster St, Omaha, NE 68131-2027 | |
| (402) 280-4626 | |
| Not Available |
| Full Name | Dr Fayak S Kamili |
|---|---|
| Gender | Female |
| Speciality | Interventional Cardiology |
| Experience | 26 Years |
| Location | 3006 Webster St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164642666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4576 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center - Centennial | Frisco, TX | Hospital |
| Baylor Scott And White Medical Center Carrollton | Carrollton, TX | Hospital |
| Baylor Scott & White The Heart Hospital - Plano | Plano, TX | Hospital |
| Entity Name | Crescent Cardiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053690735 PECOS PAC ID: 6204001027 Enrollment ID: O20111206000742 |
News Archive
A private company in the United States is being sued by a number of counties in the state of Kentucky over the potent painkilling drug OxyContin.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that lead cancer stem cell inhibitor, VS-6063 (defactinib), has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma, a rare form of lung cancer.
Precision Therapeutics announced today that The National Comprehensive Cancer Network® recently updated the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to include the use of chemosensitivity/resistance assays as part of the Principles of Chemotherapy section.
The U.S. Food and Drug Administration and other government and professional organizations today unveiled a program to monitor medical devices used in cataract surgery in an effort to stem outbreaks of a rare, inflammatory condition associated with the procedure.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
› Verified 6 days ago
| Entity Name | Texas Heart Hospital Of The Southwest Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104164755 PECOS PAC ID: 0840298303 Enrollment ID: O20130517000141 |
News Archive
A private company in the United States is being sued by a number of counties in the state of Kentucky over the potent painkilling drug OxyContin.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that lead cancer stem cell inhibitor, VS-6063 (defactinib), has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma, a rare form of lung cancer.
Precision Therapeutics announced today that The National Comprehensive Cancer Network® recently updated the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to include the use of chemosensitivity/resistance assays as part of the Principles of Chemotherapy section.
The U.S. Food and Drug Administration and other government and professional organizations today unveiled a program to monitor medical devices used in cataract surgery in an effort to stem outbreaks of a rare, inflammatory condition associated with the procedure.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fayak S Kamili, MD 4401 Coit Rd, Ste 301, Frisco, TX 75035-0507 Ph: (972) 379-7129 | Dr Fayak S Kamili, MD 3006 Webster St, Omaha, NE 68131-2027 Ph: (402) 280-4626 |
News Archive
A private company in the United States is being sued by a number of counties in the state of Kentucky over the potent painkilling drug OxyContin.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that lead cancer stem cell inhibitor, VS-6063 (defactinib), has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma, a rare form of lung cancer.
Precision Therapeutics announced today that The National Comprehensive Cancer Network® recently updated the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to include the use of chemosensitivity/resistance assays as part of the Principles of Chemotherapy section.
The U.S. Food and Drug Administration and other government and professional organizations today unveiled a program to monitor medical devices used in cataract surgery in an effort to stem outbreaks of a rare, inflammatory condition associated with the procedure.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
› Verified 6 days ago
Dr. Marium Ilahi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |